Want to join the conversation?
$KO's concentrate sales growth was in line with unit case volume growth in 2Q16. Global price/mix grew 3%, reflecting continued effective pricing and packaging initiatives across key markets. The positive price/mix in 2Q16 was driven by solid underlying pricing partially offset by 1 point of geographic mix.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?